Susquehanna International Group
LUMO

Susquehanna International Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Susquehanna International Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,381
Closed -$188K – 11281
2020
Q2 		$188K Sell
11,381
-14,918
-57% -$178K ﹤0.01% 9095
2020
Q1 		$224K Buy
26,299
+14,748
+128% +$206K ﹤0.01% 8491
2019
Q4 		$263K Sell
11,551
-1,753
-13% -$25K ﹤0.01% 8262
2019
Q3 		$190K Buy
+13,304
New +$195K ﹤0.01% 9144
2019
Q1 		– Sell
-5,940
Closed -$88.6K – 10038
2018
Q4 		$81K Buy
+5,940
New +$105K ﹤0.01% 8311
2018
Q3 		– Sell
-9,311
Closed -$283K – 10432
2018
Q2 		$399K Sell
9,311
-7,700
-45% -$353K ﹤0.01% 7260
2018
Q1 		$1.11M Buy
17,011
+5,915
+53% +$419K ﹤0.01% 5026
2017
Q4 		$810K Buy
11,096
+6,543
+144% +$541K ﹤0.01% 5663
2017
Q3 		$417K Buy
+4,553
New +$349K ﹤0.01% 6832
2017
Q1 		– Sell
-18,966
Closed -$2.71M – 10178
2016
Q4 		$1.75M Sell
18,966
-5,137
-21% -$579K ﹤0.01% 4341
2016
Q3 		$3.26M Sell
24,103
-10,948
-31% -$1.09M ﹤0.01% 2783
2016
Q2 		$3.55M Sell
35,051
-16,924
-33% -$2.1M ﹤0.01% 2679
2016
Q1 		$8.51M Buy
51,975
+33,409
+180% +$6.77M ﹤0.01% 1714
2015
Q4 		$6.08M Sell
18,566
-7,153
-28% -$2.33M ﹤0.01% 2282
2015
Q3 		$8.3M Sell
25,719
-1,102
-4% -$484K ﹤0.01% 2046
2015
Q2 		$10.7M Sell
26,821
-3,482
-11% -$1.48M ﹤0.01% 1919
2015
Q1 		$14.9M Buy
30,303
+10,103
+50% +$3.92M 0.01% 1497
2014
Q4 		$7.23M Sell
20,200
-7,563
-27% -$2.25M ﹤0.01% 2384
2014
Q3 		$5.35M Buy
27,763
+16,123
+139% +$3.54M ﹤0.01% 2914
2014
Q2 		$2.78M Buy
11,640
+2,487
+27% +$506K ﹤0.01% 4031
2014
Q1 		$2.34M Sell
9,153
-12,002
-57% -$3.67M ﹤0.01% 4064
2013
Q4 		$4.19M Buy
21,155
+13,562
+179% +$2.41M ﹤0.01% 3193
2013
Q3 		$1.28M Buy
7,593
+4,898
+182% +$788K ﹤0.01% 4860
2013
Q2 		$478K Buy
+2,695
New +$382K ﹤0.01% 6110

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group's LUMO Position: Q3 2020 in Review

Susquehanna International Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2020, closing a stake of 11,381 shares — an estimated $188K sold.

Susquehanna International Group first reported a position in LUMO in Q2 2013 and held it in 24 quarters. The position peaked at $14.9M in Q1 2015. 38 funds tracked by Wall St. Rank hold LUMO as of Q3 2020.

  • Susquehanna International Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Susquehanna International Group sold 11,381 Lumos Pharma, Inc. Common Stock shares in Q3 2020, an estimated $188K.
  • Susquehanna International Group first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 24 quarters.
  • Susquehanna International Group's Lumos Pharma, Inc. Common Stock position peaked at $14.9M in Q1 2015.
  • 38 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2020.

Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.